Summary
Gilead Sciences, Inc. (GILD) has filed an 8-K report disclosing a significant executive change. Effective December 5, 2025, Deborah H. Telman will step down from her role as Executive Vice President, Corporate Affairs and General Counsel. Her employment with the company is expected to conclude later in December. This transition marks the departure of a key member of Gilead's senior leadership. Investors should monitor any subsequent announcements regarding the replacement for Ms. Telman and the strategic implications of this change on corporate affairs and legal matters. The filing itself does not provide reasons for her departure or details about her future plans.
Key Highlights
- 1Deborah H. Telman to depart as Executive Vice President, Corporate Affairs and General Counsel.
- 2Ms. Telman's departure is effective December 5, 2025.
- 3Her employment with Gilead Sciences, Inc. will conclude later in December 2025.
- 4This filing is an 8-K Current Report.
- 5The report was filed on November 18, 2025, with an event date of November 14, 2025.
- 6The Chief Financial Officer, Andrew D. Dickinson, signed the report.